Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205121538> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4205121538 endingPage "S24" @default.
- W4205121538 startingPage "S22" @default.
- W4205121538 abstract "Chemoimmunotherapy was the backbone of treatment for CLL for approximately 2 decades, but has been replaced by targeted therapies in the majority of patients: older patients have superior progression-free survival (PFS) with ibrutinib or ibrutinib + rituximab than with bendamustine and rituximab (BR) 1 Woyach JA Ruppert AS Heerema NA et al. Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med. 2018; 379: 2517-2528 Crossref PubMed Scopus (343) Google Scholar ; patients with comorbidities have superior PFS with venetoclax + obintuzumab, 2 Fischer K Al-Sawaf O Bahlo J et al. Venetoclax and obinutuzumab in patients with CLL and coexisting conditions. N Engl J Med. 2019; 380: 2225-2236 Crossref PubMed Scopus (271) Google Scholar acalabrutinib +/- obinutuzumab 3 Sharman JP Banerji V Fogliatto LM et al. ELEVATE TN: phase 3 study of acalabrutinib combined with obinutuzumab (O) or alone vs O plus chlorambucil (Clb) in patients (Pts) with treatment-naive chronic lymphocytic leukemia (CLL). Blood. 2019; 134: 31 Crossref Scopus (24) Google Scholar or ibrutinib + obinutuzumab 4 Moreno C Greil R Demirkan F et al. Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019; 20: 43-56 Abstract Full Text Full Text PDF PubMed Scopus (223) Google Scholar than with chlorambucil + obinutuzumab; younger, fit patients have superior PFS and survival when treated with ibrutinib + rituximab than if treated with FCR. 5 Shanafelt TD Wang XV Kay NE et al. Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia. N Engl J Med. 2019; 381: 432-443 Crossref PubMed Scopus (217) Google Scholar" @default.
- W4205121538 created "2022-01-25" @default.
- W4205121538 creator A5080883357 @default.
- W4205121538 date "2020-09-01" @default.
- W4205121538 modified "2023-09-27" @default.
- W4205121538 title "BTK Inhibitors and Chemoimmunotherapy for CLL" @default.
- W4205121538 cites W1196637763 @default.
- W4205121538 cites W2169269721 @default.
- W4205121538 cites W2221325899 @default.
- W4205121538 cites W2295348655 @default.
- W4205121538 cites W2337485820 @default.
- W4205121538 cites W2489746138 @default.
- W4205121538 cites W2799621123 @default.
- W4205121538 cites W2897636215 @default.
- W4205121538 cites W2902484351 @default.
- W4205121538 cites W2902706178 @default.
- W4205121538 cites W2922286357 @default.
- W4205121538 cites W2948436219 @default.
- W4205121538 cites W2952653802 @default.
- W4205121538 cites W2958425796 @default.
- W4205121538 cites W2966190920 @default.
- W4205121538 cites W2987552010 @default.
- W4205121538 doi "https://doi.org/10.1016/s2152-2650(20)30449-3" @default.
- W4205121538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32862855" @default.
- W4205121538 hasPublicationYear "2020" @default.
- W4205121538 type Work @default.
- W4205121538 citedByCount "1" @default.
- W4205121538 countsByYear W42051215382023 @default.
- W4205121538 crossrefType "journal-article" @default.
- W4205121538 hasAuthorship W4205121538A5080883357 @default.
- W4205121538 hasConcept C126322002 @default.
- W4205121538 hasConcept C143998085 @default.
- W4205121538 hasConcept C170493617 @default.
- W4205121538 hasConcept C2776694085 @default.
- W4205121538 hasConcept C2776755627 @default.
- W4205121538 hasConcept C2777063308 @default.
- W4205121538 hasConcept C2777607594 @default.
- W4205121538 hasConcept C2777866208 @default.
- W4205121538 hasConcept C2777938653 @default.
- W4205121538 hasConcept C2778461978 @default.
- W4205121538 hasConcept C2779338263 @default.
- W4205121538 hasConcept C2779675984 @default.
- W4205121538 hasConcept C2779878957 @default.
- W4205121538 hasConcept C2780653079 @default.
- W4205121538 hasConcept C2780790343 @default.
- W4205121538 hasConcept C2781442060 @default.
- W4205121538 hasConcept C42362537 @default.
- W4205121538 hasConcept C71924100 @default.
- W4205121538 hasConcept C90059517 @default.
- W4205121538 hasConceptScore W4205121538C126322002 @default.
- W4205121538 hasConceptScore W4205121538C143998085 @default.
- W4205121538 hasConceptScore W4205121538C170493617 @default.
- W4205121538 hasConceptScore W4205121538C2776694085 @default.
- W4205121538 hasConceptScore W4205121538C2776755627 @default.
- W4205121538 hasConceptScore W4205121538C2777063308 @default.
- W4205121538 hasConceptScore W4205121538C2777607594 @default.
- W4205121538 hasConceptScore W4205121538C2777866208 @default.
- W4205121538 hasConceptScore W4205121538C2777938653 @default.
- W4205121538 hasConceptScore W4205121538C2778461978 @default.
- W4205121538 hasConceptScore W4205121538C2779338263 @default.
- W4205121538 hasConceptScore W4205121538C2779675984 @default.
- W4205121538 hasConceptScore W4205121538C2779878957 @default.
- W4205121538 hasConceptScore W4205121538C2780653079 @default.
- W4205121538 hasConceptScore W4205121538C2780790343 @default.
- W4205121538 hasConceptScore W4205121538C2781442060 @default.
- W4205121538 hasConceptScore W4205121538C42362537 @default.
- W4205121538 hasConceptScore W4205121538C71924100 @default.
- W4205121538 hasConceptScore W4205121538C90059517 @default.
- W4205121538 hasLocation W42051215381 @default.
- W4205121538 hasLocation W42051215382 @default.
- W4205121538 hasOpenAccess W4205121538 @default.
- W4205121538 hasPrimaryLocation W42051215381 @default.
- W4205121538 hasRelatedWork W1550739321 @default.
- W4205121538 hasRelatedWork W2284975440 @default.
- W4205121538 hasRelatedWork W2592618792 @default.
- W4205121538 hasRelatedWork W2606155555 @default.
- W4205121538 hasRelatedWork W2620696047 @default.
- W4205121538 hasRelatedWork W2902300122 @default.
- W4205121538 hasRelatedWork W2905243278 @default.
- W4205121538 hasRelatedWork W3029558579 @default.
- W4205121538 hasRelatedWork W3086386184 @default.
- W4205121538 hasRelatedWork W4312948978 @default.
- W4205121538 hasVolume "20" @default.
- W4205121538 isParatext "false" @default.
- W4205121538 isRetracted "false" @default.
- W4205121538 workType "article" @default.